UNH Stock Jumps 3% as UnitedHealth Lifts 2026 Profit Outlook

UNH stock rose about 3% in premarket trading Tuesday after UnitedHealth Group beat third-quarter earnings estimates and raised its full-year profit outlook. Investors searching the ticker this morning are looking at the nation's largest private insurer reporting adjusted earnings of $4.69 per share against the $4.14 analysts expected, on revenue of $112.69 billion versus a $111.40 billion forecast.

The story inside the print is the medical cost ratio, the share of premiums UnitedHealth spends on medical care. It came in at 88.4% for the quarter, down from 89.9% in the same period of 2025 and better than the 89.9% StreetAccount consensus. A lower ratio means the company kept more of each premium dollar, and after more than two years of elevated healthcare costs across the industry, that number is what sent the ticker up.

Related reading: Walmart Q2 FY27: Comp Sales Miss Sinks Stock 8% Despite Beat.

Chief financial officer Wayne DeVeydt told CNBC the company is executing on value-based care and artificial intelligence investments that are steering patients toward lower-cost settings. Acute hospital admissions among UnitedHealth members fell 15% year over year through the quarter, while home health admissions rose 10%. "You're finding more members are actually getting into a lower-cost care environment," DeVeydt said. He still cautioned that medical costs "continue to be elevated versus historical norms," adding that the independent dispute resolution process under the No Surprises Act adds at least 100 basis points to total medical costs.

On the earnings line, UnitedHealth reported net income of $4.10 billion, or $4.56 per diluted share, up from $2.35 billion, or $2.59 per share, in the third quarter of 2025. Revenue slipped to $112.69 billion from $113.16 billion a year earlier, a reflection of the company deliberately shrinking membership and exiting unprofitable contracts to stabilize margins. The company now expects full-year 2026 adjusted earnings of at least $20.50 per share, raised from an earlier outlook of $19.50 to $20.00, and pointing to the three consecutive strong quarters the turnaround plan has now produced.

Related reading: Samsung Profit Estimate Surges 782%, but AI Memory Mix Is Unclear.

For shareholders and for the health insurance sector more broadly, the takeaway is that the bill is being brought under control. UnitedHealthcare served 48.3 million consumers and generated $86.3 billion in revenue, while Optum drove $66.9 billion of revenue and cared for over 120 million patients and consumers. The company bought back $5.0 billion of stock and paid $6.2 billion in dividends in the first nine months of the year, according to the release.

Looked at from a sector standpoint, this is a bellwether print rather than a single-stock story. Managed-care names spent the past two years under a cloud as medical cost ratios climbed across the group and Medicare Advantage utilization ate into margins. UnitedHealth reporting a lower ratio now, and lifting guidance on the strength of it, is the first concrete evidence that pricing discipline and care redesign are showing up in the margin instead of just in management commentary. When the largest private insurer in the country says cost pressure is easing, the rest of the group is measured against that bar when each reports in the weeks after.

Related reading: United Airlines Stock Drops 2% as Susquehanna Cuts Price Target to $150.

The next test is whether the ratio stays this contained through the fourth quarter, when year-end utilization data lands and the industry resets pricing for 2027 Medicare Advantage plans. DeVeydt expects the initiatives to compound into next year. For now, the print answers the Tuesday morning search: UnitedHealth beat, raised, and the medical cost pressure that dogged the sector for two years is measurably easing.

Related reading: Microsoft Stock Climbs Toward $540 as Maia 300 AI Chip Debuts, Targets Hit $600.

This content is for informational purposes only and does not constitute financial advice. Past performance is not indicative of future results. Consult a qualified financial advisor before making investment decisions.